Exclusive

Publication

Byline

Location

Drug makers show strong resilience in H1 FY26 despite adversities

Dhaka, Feb. 2 -- The leading drug manufacturers posted double-digit year-on-year profit growth in the first half (H1) of the current financial year, driven by higher sales and lower input costs amid a... Read More